Перейти
на сайт журнала "Врач" |
Перейти на сайт журнала "Медицинская сестра"
|
Перейти на сайт журнала "Фармация"
|
Перейти на сайт журнала "Молекулярная медицина"
|
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
|
Журнал включен в российские и международные библиотечные и реферативные базы данных
ВАК (Россия)
|
РИНЦ (Россия)
|
Эко-Вектор (Россия)
|
CHARACTERISTICS OF SELENIUM EXCHANGE IN CHILDREN WITH CEREBRAL PALSY
DOI: https://doi.org/10.29296/25877313-2019-11-07
Issue:
11
Year:
2019
A number of studies demonstrate high risk of micronutrient disorders in children with cerebral palsy. However, the existing data on trace ele-ment status and particularly selenium are insufficient. Therefore, the objective of the present study is assessment of serum, urinary, and hair Se lev-els in children with cerebral palsy. Se levels were assessed in 52 children with cerebral palsy aged 2-8 y.o. and 52 healthy controls using inductively-coupled plasma mass spectrometry at NexION 300D (PerkinElmer, USA). The obtained data demonstrate that serum Se levels in cerebral palsy were 12% higher than the control values (0.088±0.013 vs 0.099±0.034 µg/ml; p=0.037). Oppositely, hair Se content was characterized by a 5% decrease when compared to the healthy controls (0.386 (0.308-0.498) vs 0.368 (0.250-0.467) µg/g; p = 0.042). No significant group difference in urinary Se lev-els were observed. Multiple regression analysis demonstrated that in a crude model both serum (β=0.233; p=0.017) and hair (β=-0.207; p=0.035) Se levels were significantly associated with cerebral palsy. Given a significant role of selenium in psychomotor dysfunction, personalized assessment of Se status is recommended to children with cerebral palsy in order to manage the strategies of pharmaco-nutraceutical correction of metal-ligand ho-meostasis.
Keywords:
cerebral palsy
selenium
inductively-coupled plasma mass spectrometry
selenoprotein
References:
- Blair E., Cans C., Sellier E. Epidemiology of the cerebral palsies. In Cerebral Palsy. Cham: Springer, 2018. R. 19-28.
- García C.C., Alcocer-Gamboa A., Ruiz M.P., Caballero I.M. et al. Metabolic, cardiorespiratory, and neuromuscular fitness performance in children with cerebral palsy: a comparison with healthy youth. Journal of exercise rehabilitation. 2016; 12(2):124-131.
- Vargus-Adams J. Health-related quality of life in childhood cerebral palsy. Archives of physical medicine and rehabilitation. 2005; 86(5):940-945.
- Schoendorfer N., Boyd R., Davies P.S. Micronutrient adequacy and morbidity: paucity of information in children with cerebral palsy. Nutrition reviews. 2010; 68(12):739-748.
- Hillesund E., Skranes J., Trygg K.U., Bøhmer T. Micronutrient status in children with cerebral palsy. Acta Paediatrica. 2007; 96(8):1195-1198.
- Tinkov A.A., Ajsuvakova O.P., Skalny A.V. A Case-Control Study of Essential and Toxic Trace Elements and Minerals in Hair of 0–4-Year-Old Children with Cerebral Palsy. Biological trace element research. 2019; doi 10.1007/s12011-019-01876-3 [v pechati].
- Bebars G.M., Afifi M.F., Mahrous D.M., Okaily N.E., Mounir S.M., Mohammed E.A. Assessment of some micronutrients serum levels in children with severe acute malnutrition with and without cerebral palsy-A follow up case control study. Clinical Nutrition Experimental. 2019; 23: 34-43.
- Fradejas-Villar N., Schweizer U. Selenium and Neurodevelopment. In Selenium. Cham: Springer, 2018. R. 177-192.
- Bräuer A.U., Savaskan N.Ε. Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Reviews in the Neurosciences. 2004; 15(1):19-32.
- Vinceti M., Mandrioli J., Borella P. et al. Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies. Toxicology letters. 2014; 230(2): 295-303.
- Asmah R.H., Anyele A., Asare-Anane H. et al. Micronutrient levels and antioxidant status in pediatric cerebral palsy patients. Oxidants and Antioxidants in Medical Science. 2015; 4: 73-77.
- Raman A.V., Pitts M.W., Seyedali A., Hashimoto A.C. et al. Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction. Genes, Brain and Behavior. 2012; 11(5): 601-613.
- Iwama K., Sasaki M., Hirabayashi S., Ohba C., Iwabuchi E. et al. Milder progressive cerebellar atrophy caused by biallelic SEPSECS mutations. Journal of human genetics. 2016; 61(6): 527-531.
- Polanska K., Krol A., Sobala W., Gromadzinska J., Brodzka R. et al. Selenium status during pregnancy and child psychomotor development - Polish Mother and Child Cohort study. Pediatric research. 2016; 79(6): 863-874.
- Amorós R., Murcia M., Ballester F., Broberg K. et al. Selenium status during pregnancy: Influential factors and effects on neuropsychological development among Spanish infants. Science of the Total Environment. 2018; 610: 741-749.
- Cardoso B.R., Hare D.J., Bush A.I. The Role of Selenium in Neurodegenerative Diseases. In Biometals in Neurodegenerative Diseases. Academic Press, 2017. R. 35-49.
- EHlektronnyj resurs: https:// lifebio.wiki›ресвератрол.
- Baraboj V.A. Fenol'nye soedineniya vinogradnoj lozy: struktura, antioksidantnaya aktivnost', primenenie // Biotechnologia Acta. 2009. T. 2. № 2. S. 6769.
- Moiseeva A.M., ZHeleznyak N.V., Generalova A.G., Moiseev D.V. Fitoaleksin resveratrol: metody opredeleniya, mekhanizmy dejstviya, perspektivy klinicheskogo primeneniya // Vestnik farmacii. 2012. № 1(55). S. 6373.